These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8902776)

  • 1. Significance of aPL IgG subclasses.
    Sammaritano LR
    Lupus; 1996 Oct; 5(5):436-9. PubMed ID: 8902776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis.
    Sammaritano LR; Ng S; Sobel R; Lo SK; Simantov R; Furie R; Kaell A; Silverstein R; Salmon JE
    Arthritis Rheum; 1997 Nov; 40(11):1998-2006. PubMed ID: 9365089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients.
    Arvieux J; Roussel B; Ponard D; Colomb MG
    Clin Exp Immunol; 1994 Feb; 95(2):310-5. PubMed ID: 8306507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus.
    Tsutsumi A; Koike T; Ichikawa K; Shimada K; Takabayashi K; Tomioka H; Yoshida S
    J Rheumatol; 1988 Dec; 15(12):1764-7. PubMed ID: 3265958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases.
    Zouali M; Jefferis R; Eyquem A
    Immunology; 1984 Mar; 51(3):595-600. PubMed ID: 6230310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus.
    Gharavi AE; Harris EN; Lockshin MD; Hughes GR; Elkon KB
    Ann Rheum Dis; 1988 Apr; 47(4):286-90. PubMed ID: 3129997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases.
    Blanco F; Kalsi J; Ravirajan CT; Speight P; Bradwell AR; Isenberg DA
    Lupus; 1992 Dec; 1(6):391-9. PubMed ID: 1304408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
    de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
    Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
    Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
    Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
    Zeinab M; Hiam KM; Edmond C; Assem E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():77-83. PubMed ID: 25438246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up.
    Esnault VL; Jayne DR; Weetman AP; Lockwood CM
    Immunology; 1991 Dec; 74(4):714-8. PubMed ID: 1664417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG-subclass expression of anti-DNA and anti-ribonucleoprotein autoantibodies in human malaria.
    Zouali M; Druilhe P; Eyquem A
    Clin Exp Immunol; 1986 Nov; 66(2):273-8. PubMed ID: 3493096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
    J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.